CAS ID: | 69-65-8 |
Molecular Formula: | C6H14O6 |
Molecular Weight: | 182.2 g/mol |
Monoisotopic Mass: | 182.079 g/mol |
Class: | Small Molecule |
Natural Product: | Yes |
Other Names: | Diosmol | BRONCHITOL | MANNA SUGAR | RESECTISOL | E421 | MANNITE | MANNITOL | OSMITROL | ARIDOL KIT | Alexitol sodium | D-MANNITOL |
Analysis: | Drug repositioning mechanism analysis |
Trial Record 1
ClinicalTrial ID | NCT00117208 | Disease | Cystic fibrosis |
Phase | Phase 2 | Status | Completed |
First Received | July 4, 2005 | Last Verified | February 2, 2010 |
Sponsor | Pharmaxis |
Trial Record 2
ClinicalTrial ID | NCT00446680 | Disease | Cystic fibrosis |
Phase | Phase 3 | Status | Completed |
First Received | March 13, 2007 | Last Verified | June 25, 2010 |
Sponsor | Pharmaxis |
Trial Record 3
ClinicalTrial ID | NCT00792714 | Disease | Cystic fibrosis |
Phase | Phase 1 | Status | Completed |
First Received | November 18, 2008 | Last Verified | February 2, 2010 |
Sponsor | Pharmaxis |
Trial Record 4
ClinicalTrial ID | NCT00251056 | Disease | Cystic fibrosis |
Phase | Phase 2 | Status | Completed |
First Received | November 9, 2005 | Last Verified | August 29, 2008 |
Sponsor | Pharmaxis |
Trial Record 5
ClinicalTrial ID | NCT02134353 | Disease | Cystic fibrosis |
Phase | Phase 3 | Status | Completed |
First Received | May 9, 2014 | Last Verified | March 9, 2018 |
Sponsor | Pharmaxis |
Trial Record 6
ClinicalTrial ID | NCT00455130 | Disease | Cystic fibrosis |
Phase | Phase 2 | Status | Completed |
First Received | April 3, 2007 | Last Verified | February 2, 2010 |
Sponsor | Pharmaxis |
Trial Record 7
ClinicalTrial ID | NCT01883531 | Disease | Cystic fibrosis |
Phase | Phase 2 | Status | Completed |
First Received | June 21, 2013 | Last Verified | October 14, 2015 |
Sponsor | Pharmaxis |
Trial Record 8
ClinicalTrial ID | NCT01887197 | Disease | Cystic fibrosis |
Phase | Phase 1 | Status | Completed |
First Received | June 26, 2013 | Last Verified | November 6, 2018 |
Sponsor | Tim Corcoran |
Trial Record 9
ClinicalTrial ID | NCT01309178 | Disease | Cystic fibrosis |
Phase | Phase 2 | Status | Unknown |
First Received | March 7, 2011 | Last Verified | March 7, 2011 |
Sponsor | University Children’s Hospital Tuebingen |
Trial Record 10
ClinicalTrial ID | NCT00630812 | Disease | Cystic fibrosis |
Phase | Phase 3 | Status | Completed |
First Received | March 7, 2008 | Last Verified | August 15, 2012 |
Sponsor | Pharmaxis |